BIOLOPTIM: implementation of therapeutic drug monitoring for biologicals in psoriasis and hidradenitis supparativa

Design and characterization of non-viral carriers for siRNA delivery in human skin

Evaluation of the therapeutic possiblities of siRNA in the treatment of hyperpigmentation of the skin

Identification of biomarker candidates to predict therapeutic response in psoriasis.

Inhibition vanmyosine Va melanosoominteragerende transcripts as a new tool in the modulation of hyperpigmentation of the skin.

Innovation in immune mediated inflammatory skin diseases.

Investigation of regulatory T cell function in autoimmune skin diseases: study of a pemhigus vulgaris model

Proof-of-mechanism in psoriasis: towards a novel drug therapy and tools for its clinical evaluation

Proof-of-mechanism in psoriasis: towards a novel drug therapy and tools for its clinical evaluation

Synthesis and characterization of non-viral liposomal carriers for the local application of siRNA molecules and antagomirs in the therapeutic treatment of psoriasis

Synthesis and characterization of non-viral liposomal carriers for the local application of siRNA molecules and antagomirs therapeutic treatment of psoriasis

The mechanism of peripheral tolerance to self-antigens by melanocytic breaks at vitiligo: a clinical and experimental study

Translational study of the inflammatory aspects of vitiligo: unraveling the danger model

A MESO QuickPlex SQ system to measure single or multiple immunotargets in biofluids

Development of a data-informed causal expert system for personalized treatment recommendations

DNA methylation markers to predict treatment success of biologicals in Crohn’s disease.

Inhibition vanmyosine Va melanosoominteragerende transcripts as a new tool in the modulation of hyperpigmentation of the skin.